To investigate further the requirement of SORLA expression for the proliferation of HER2-dependent cancer cells, we silenced SORLA in the intermediate SORLA expressers, MDA-MB-361 cells, with a 3′UTR targeting siRNA and then re-expressed SORLA in the same cells. This evidence concerns the gene ERBB2 and cancer.